Trending Now
Business
Wells Fargo Co-Signs ‘Shock Exchange’: Generic Restasis Almost Here
The biggest story in the financial markets right now is Allergan, one of the most celebrated biotechs on Wall Street. As recently as last...
Allergan: Botox Biosimilar From Mylan And Revance Sounds Ominous
Mylan (MYL) and Revance Therapeutics (RVNC) announced a global collaboration and license agreement to develop and commercialize a biosimilar for Allergan's (AGN) Botox:
Mylan N.V....
Lifestyle today
Entertainment
Tom Brady, Jalen Ramsey Talk Hella Reckless During Warm-Ups
The AFC and NFC championship games are both being played today. In the NFC the Philadelphia Eagles take on the Minnesota Vikings, while the...
Endo – Coronavirus Could Spur Sales Growth
Endo International (ENDP) is still one of the market's most frustrating, confounding stocks. The stock hit a 52-week high of over $18 in the...
Allergan: Et Tu, Novartis?
Last week Allergan (AGN) lost an appeal in its attempt to protect its Combigan eye drug from generic competition posed by Novartis AG's (NVS),...
Fed Backstops The Recession Shock Exchange Predicted
The coronavirus has led to social distancing, which has caused millions of Americans to be displaced from work. Policymakers have braced themselves for poor...
California Governor Jerry Brown Exposes Valeant, Teva For Price Gouging
California and Vermont have been in the forefront of the drug price debate. They have both attempted to shine a light on drug companies...
Ken Griffin’s Citadel Advisors Triples Stake In Endo
Endo International (ENDP) has been on a tear as of late. The stock is up about 150% since late May when I wrote a...
Allergan: Growth Is Dead
Allergan's (AGN) Q2 results appeared to be pretty strong, at least on the surface. The company reported revenue of $4.0 billion and EBITDA of...
Endo International: Will Hedge Funds Pile In?
The fortunes of Endo International are starting to turn. The stock is down about 7% Y/Y, but has bounced over 40% YTD. Albeit, the...
























































































































